Accutest Biologics Private Limited - Company Profile

It is a life sciences private limited company based in Navi Mumbai, Maharashtra, India, established in 2012.

2012 Navi Mumbai, Maharashtra, India Active

Last Updated: March 06, 2026

About Accutest Biologics Private Limited

Accutest Biologics Private Limited, a active private limited company, was established on 03 August 2012 in Navi Mumbai, Maharashtra, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U74900MH2012PTC234115. Registered under ROC Roc Mumbai Ii. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 M.

Formerly known as Quantimmune Solutions Private Limited. It upholds a compliant status. Its leadership includes Uma Ramachandran (Director), Ashvin Joseph George (Nominee Director), Devireddy Reddy Madhusudhana (Director). Past directors included Uma Ramachandran, Mallikarjun Narayan Dixit, Satish Vithhal Sawant. It holds ₹60.00 Cr open charges and ₹131.86 Cr settled loans. Its latest AGM occurred on 13 November 2025, with the balance sheet filed on 31 March 2025. It is based at A-77, Midc, Ttc Industrial Area, Khairane Navi Mumbai, Navi Mumbai, Maharashtra, 400709.

Company Details

CIN/LLPIN
U74900MH2012PTC234115
Registration Number
234115
Incorporation Date
03 August 2012
Authorized Capital
₹2.00 Cr
Paid-Up Capital
₹1.00 M
ROC Code
Roc Mumbai Ii
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 2.00 Cr as on 06-03-2026
Paid Up Capital ₹ 1.00 M as on 06-03-2026
Company Age 13 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 60.00 Cr as on 06-03-2026
Satisfied Charges ₹ 131.86 Cr as on 06-03-2026
Revenue Growth **** -91.26% (FY 2023)
Profit Growth **** 372.12% (FY 2023)
Ebitda **** -241.29% (FY 2023)
Net Worth 32.99% (FY 2023)
Total Assets -45.44% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Accutest Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Accutest Biologics Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Uma Ramachandran	Director	07 Jun 2025	Current
Ashvin Joseph George	Nominee Director	07 Oct 2022	Current
Devireddy Reddy Madhusudhana	Director	07 Jun 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	12 Nov 2025	Past
Pramod Abcsdd	Director	18 Mar 2020	Past
Pramod Abcsdd	Director	11 Dec 2023	Past
Pramod Abcsdd	Nominee Director	06 Jul 2025	Past
Pramod Abcsdd	Director	07 Oct 2022	Past
Pramod Abcsdd	Director	26 Jun 2013	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Accutest Biologics.

Accutest Biologics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 91.26% decrease. The company also saw a substantial improvement in profitability, with a 372.12% increase in profit. The company's net worth Soared by an impressive increase of 32.99%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-91.26%

*******

Revenue from Operations

*******

-92.98%

*******

Total Assets

*******

-45.44%

*******

Profit or Loss

*******

372.12%

*******

Net Worth

*******

32.99%

*******

EBITDA

*******

-241.29%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Accutest Biologics?

In 2023, Accutest Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹600,000,000.00

Satisfied Charges

₹1,318,576,961.00

Charges Breakdown by Lending Institutions

Others : 30.00 Cr
Tata Capital Financial Services Limited : 30.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
20 Oct 2025	Others	₹30.00 Cr	Open
03 Oct 2022	Tata Capital Financial Services Limited	₹30.00 Cr	Open
05 Nov 2018	Others	₹112.04 Cr	Satisfied
09 Jul 2014	The Shamrao Vithal Co-Operative Bank Limited	₹1.15 Cr	Satisfied
07 Feb 2013	The Shamrao Vithal Co-Operative Bank Limited	₹18.67 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Accutest Biologics?

Unlock and access historical data on people associated with Accutest Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Accutest Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accutest Biologics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Accutest Biologics

Recent Activity within the Organization

Annual General Meeting

Accutest Biologics Private Limited last Annual general meeting of members was held on 13 Nov 2025 as per latest MCA records. was recorded as a recent event.
13 Nov 2025
Director Appointment

Anjali Bharatkumar Sampat was appointed as a Company Secretary was appointed as a Company Secretary on 06 Nov 2025 & has been associated with this company since 7 months 6 days . was recorded as a recent event.
06 Nov 2025
Charges

The activity A charge with Others amounted to Rs. 30.00 Cr with Charge ID 101177859 was registered on 20 Oct 2025. was completed.
20 Oct 2025
Director Appointment

Progress on Uma Ramachandran was appointed as a Director was appointed as a Director on 07 Jun 2025 & has been associated with this company since 1 year 5 days . was documented.
07 Jun 2025
Director Appointment

The activity Devireddy Reddy Madhusudhana was appointed as a Director was appointed as a Director on 07 Jun 2025 & has been associated with this company since 1 year 5 days . was completed.
07 Jun 2025
Balance Sheet

Progress on Accutest Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii. was documented.
31 Mar 2025

Explore recent activity and updates - View Recent Activity